{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:34:25Z","timestamp":1787960065333,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"special fund for clinical research project","award":["22LCYY-LH2"],"award-info":[{"award-number":["22LCYY-LH2"]}]},{"name":"Social Development - Key Projects","award":["BE2020699"],"award-info":[{"award-number":["BE2020699"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08469-z","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T08:03:34Z","timestamp":1727683414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of the screening with coronary computed tomography angiography on lipid management and risk factors control in an asymptomatic Chinese population: a community-based, parallel-group, open-label, randomized clinical trial (RESPECT2)"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongna","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-7224","authenticated-orcid":false,"given":"Long Jiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"8469_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.7326\/M20-4680","volume":"173","author":"JT Reston","year":"2020","unstructured":"Reston JT, Buelt A, Donahue MP, Neubauer B, Vagichev E, McShea K. Interventions to improve statin tolerance and adherence in patients at risk for cardiovascular disease\u202f: a systematic review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia. Ann Intern Med. 2020;173:806\u201312.","journal-title":"Ann Intern Med."},{"key":"8469_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670\u201381.","journal-title":"Lancet."},{"key":"8469_CR3","first-page":"Cd006887","volume":"3","author":"KN Karmali","year":"2017","unstructured":"Karmali KN, Persell SD, Perel P, Lloyd-Jones DM, Berendsen MA, Huffman MD. Risk scoring for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2017;3:Cd006887.","journal-title":"Cochrane Database Syst Rev."},{"key":"8469_CR4","doi-asserted-by":"publisher","first-page":"n1493","DOI":"10.1136\/bmj.n1493","volume":"374","author":"ST Simon","year":"2021","unstructured":"Simon ST, Kini V, Levy AE, Ho PM. Medication adherence in cardiovascular medicine. BMJ. 2021;374:n1493.","journal-title":"BMJ"},{"key":"8469_CR5","first-page":"2473","volume":"38","author":"A Vonbank","year":"2017","unstructured":"Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, et al. Comprehensive efforts to increase adherence to statin therapy. Eur Heart J. 2017;38:2473\u20139.","journal-title":"Eur Heart J"},{"key":"8469_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.7326\/M18-1932","volume":"170","author":"J Lu","year":"2019","unstructured":"Lu J, Lu Y, Yang H, Bilige W, Li Y, Schulz W, et al. Characteristics of high cardiovascular risk in 1.7 million Chinese adults. Ann Intern Med. 2019;170:298\u2013308.","journal-title":"Ann Intern Med."},{"key":"8469_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/JCN.0000000000000103","volume":"30","author":"JE Johnson","year":"2015","unstructured":"Johnson JE, Gulanick M, Penckofer S, Kouba J. Does knowledge of coronary artery calcium affect cardiovascular risk perception, likelihood of taking action, and health-promoting behavior change? J Cardiovasc Nurs. 2015;30:15\u201325.","journal-title":"J Cardiovasc Nurs"},{"key":"8469_CR8","first-page":"e596","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation. 2019;140:e596\u2013646.","journal-title":"Circulation"},{"key":"8469_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0140-6736(18)33079-4","volume":"393","author":"R Kones","year":"2019","unstructured":"Kones R, Rumana U, Morales-Salinas A. Confronting the most challenging risk factor: non-adherence. Lancet. 2019;393:105\u20136.","journal-title":"Lancet"},{"key":"8469_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40:87\u2013165.","journal-title":"Eur Heart J"},{"key":"8469_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407\u201377.","journal-title":"Eur Heart J"},{"key":"8469_CR12","first-page":"e368","volume":"144","author":"M Gulati","year":"2021","unstructured":"Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;144:e368\u2013454.","journal-title":"Circulation"},{"key":"8469_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00330-015-3868-z","volume":"26","author":"LJ Zhang","year":"2016","unstructured":"Zhang LJ, Wang Y, Schoepf UJ, Meinel FG, Bayer RR 2nd, Qi L, et al. Image quality, radiation dose, and diagnostic accuracy of prospectively ECG-triggered high-pitch coronary CT angiography at 70 kVp in a clinical setting: comparison with invasive coronary angiography. Eur Radiol. 2016;26:797\u2013806.","journal-title":"Eur Radiol"},{"key":"8469_CR14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jcmg.2023.03.007","volume":"16","author":"K Whitmore","year":"2023","unstructured":"Whitmore K, Zhou Z, Chapman N, Huynh Q, Magnussen CG, Sharman JE, et al. Impact of patient visualization of cardiovascular images on modification of cardiovascular risk factors: a meta-analysis. JACC Cardiovasc Imaging. 2023;16:1069\u201381.","journal-title":"JACC Cardiovasc Imaging"},{"key":"8469_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jcmg.2021.11.006","volume":"15","author":"JB Muhlestein","year":"2022","unstructured":"Muhlestein JB, Knowlton KU, Le VT, Lappe DL, May HT, Min DB, et al. Coronary artery calcium versus pooled cohort equations score for primary prevention guidance: randomized feasibility trial. JACC Cardiovasc Imaging. 2022;15:843\u201355.","journal-title":"JACC Cardiovasc Imaging"},{"key":"8469_CR16","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1093\/eurheartj\/ehad275","volume":"44","author":"L Tokgozoglu","year":"2023","unstructured":"Tokgozoglu L, Morrow DA, Nicholls SJ. Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers. Eur Heart J. 2023;44:2292\u2013304.","journal-title":"Eur Heart J"},{"key":"8469_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.7326\/M22-3027","volume":"176","author":"A Fuchs","year":"2023","unstructured":"Fuchs A, K\u00fchl JT, Sigvardsen PE, Afzal S, Knudsen AD, M\u00f8ller MB, et al. Subclinical coronary atherosclerosis and risk for myocardial infarction in a Danish cohort\u202f: a prospective observational cohort study. Ann Intern Med. 2023;176:433\u201342.","journal-title":"Ann Intern Med"},{"key":"8469_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.121.055340","volume":"144","author":"G Bergstr\u00f6m","year":"2021","unstructured":"Bergstr\u00f6m G, Persson M, Adiels M, Bj\u00f6rnson E, Bonander C, Ahlstr\u00f6m H, et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144:916\u201329.","journal-title":"Circulation"},{"key":"8469_CR19","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jcmg.2022.03.010","volume":"15","author":"K Nasir","year":"2022","unstructured":"Nasir K, Cainzos-Achirica M, Valero-Elizondo J, Ali SS, Havistin R, Lakshman S, et al. Coronary atherosclerosis in an asymptomatic U.S. population: Miami Heart Study at Baptist Health South Florida. JACC Cardiovasc Imaging. 2022;15:1604\u201318.","journal-title":"JACC Cardiovasc Imaging."},{"key":"8469_CR20","first-page":"221","volume":"51","author":"Joint Committee on the Chinese Guidelines for Lipid Management","year":"2023","unstructured":"Joint Committee on the Chinese Guidelines for Lipid Management. Chinese guidelines for lipid management (2023). Chin J Cardiol. 2023;51:221\u201355.","journal-title":"Chin J Cardiol."},{"key":"8469_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jcct.2022.07.002","volume":"16","author":"RC Cury","year":"2022","unstructured":"Cury RC, Leipsic J, Abbara S, Achenbach S, Berman D, Bittencourt M, et al. CAD-RADS\u2122 2.0 - 2022 Coronary Artery Disease-Reporting and Data System: an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr. 2022;16:536\u201357.","journal-title":"J Cardiovasc Comput Tomogr."},{"key":"8469_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2017.12.069","volume":"260","author":"M Zhang","year":"2018","unstructured":"Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults. Int J Cardiol. 2018;260:196\u2013203.","journal-title":"Int J Cardiol"},{"key":"8469_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.119.043731","volume":"141","author":"S Xia","year":"2020","unstructured":"Xia S, Du X, Guo L, Du J, Arnott C, Lam CSP, et al. Sex differences in primary and secondary prevention of cardiovascular disease in China. Circulation. 2020;141:530\u20139.","journal-title":"Circulation"},{"key":"8469_CR24","doi-asserted-by":"publisher","first-page":"e1041","DOI":"10.1016\/S2468-2667(22)00170-0","volume":"7","author":"X Zhang","year":"2022","unstructured":"Zhang X, Lu J, Yang Y, Cui J, Zhang X, Xu W, et al. Cardiovascular disease prevention and mortality across 1 million urban populations in China: data from a nationwide population-based study. Lancet Public Health. 2022;7:e1041\u201350.","journal-title":"Lancet Public Health"},{"key":"8469_CR25","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1016\/S2468-2667(20)30191-2","volume":"5","author":"X Li","year":"2020","unstructured":"Li X, Wu C, Lu J, Chen B, Li Y, Yang Y, et al. Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Health. 2020;5:e672\u201381.","journal-title":"Lancet Public Health"},{"key":"8469_CR26","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet."},{"key":"8469_CR27","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.jacc.2020.11.021","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: a compass for global action. J Am Coll Cardiol. 2020;76:2980\u20131.","journal-title":"J Am Coll Cardiol"},{"key":"8469_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2021.08.002","volume":"334","author":"P Venkataraman","year":"2021","unstructured":"Venkataraman P, Huynh Q, Nicholls SJ, Stanton T, Watts GF, Marwick TH, et al. Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: results from a pragmatic, randomised controlled trial. Atherosclerosis. 2021;334:57\u201365.","journal-title":"Atherosclerosis"},{"key":"8469_CR29","doi-asserted-by":"publisher","first-page":"100199","DOI":"10.1016\/j.ajpc.2021.100199","volume":"7","author":"A Bengtsson","year":"2021","unstructured":"Bengtsson A, Norberg M, Ng N, Carlberg B, Gr\u00f6nlund C, Hultdin J, et al. The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: results from the VIPVIZA randomized clinical trial. Am J Prev Cardiol. 2021;7:100199.","journal-title":"Am J Prev Cardiol"},{"key":"8469_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0140-6736(18)32818-6","volume":"393","author":"U N\u00e4slund","year":"2019","unstructured":"N\u00e4slund U, Ng N, Lundgren A, Fh\u00e4rm E, Gr\u00f6nlund C, Johansson H, et al. Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial. Lancet. 2019;393:133\u201342.","journal-title":"Lancet"},{"key":"8469_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/archinternmed.2011.1326","volume":"172","author":"N Rodondi","year":"2012","unstructured":"Rodondi N, Collet TH, Nanchen D, Locatelli I, Depairon M, Aujesky D, et al. Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial. Arch Intern Med. 2012;172:344\u201352.","journal-title":"Arch Intern Med"},{"key":"8469_CR32","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jacc.2011.01.019","volume":"57","author":"A Rozanski","year":"2011","unstructured":"Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Peats L, Wong ND, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol. 2011;57:1622\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"8469_CR33","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1001\/jama.289.17.2215","volume":"289","author":"PG O\u2019Malley","year":"2003","unstructured":"O\u2019Malley PG, Feuerstein IM, Taylor AJ. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. JAMA. 2003;289:2215\u201323.","journal-title":"JAMA"},{"key":"8469_CR34","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227\u2013337.","journal-title":"Eur Heart J"},{"key":"8469_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111\u201388.","journal-title":"Eur Heart J"},{"key":"8469_CR36","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","volume":"141","author":"MC Williams","year":"2020","unstructured":"Williams MC, Kwiecinski J, Doris M, McElhinney P, D\u2019Souza MS, Cadet S, et al. Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART). Circulation. 2020;141:1452\u201362.","journal-title":"Circulation"},{"key":"8469_CR37","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","volume":"365","author":"SJ Nicholls","year":"2011","unstructured":"Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, et al. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med. 2011;365:2078\u201387.","journal-title":"N Engl J Med"},{"key":"8469_CR38","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","volume":"295","author":"SE Nissen","year":"2006","unstructured":"Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006;295:1556\u201365.","journal-title":"JAMA"},{"key":"8469_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jacc.2013.03.058","volume":"62","author":"AS Kini","year":"2013","unstructured":"Kini AS, Baber U, Kovacic JC, Limaye A, Ali ZA, Sweeny J, et al. Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). J Am Coll Cardiol. 2013;62:21\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"8469_CR40","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.jacc.2023.08.019","volume":"82","author":"FG Biccir\u00e8","year":"2023","unstructured":"Biccir\u00e8 FG, H\u00e4ner J, Losdat S, Ueki Y, Shibutani H, Otsuka T, et al. Concomitant coronary atheroma regression and stabilization in response to lipid-lowering therapy. J Am Coll Cardiol. 2023;82:1737\u201347.","journal-title":"J Am Coll Cardiol"},{"key":"8469_CR41","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.2022.5218","volume":"327","author":"L R\u00e4ber","year":"2022","unstructured":"R\u00e4ber L, Ueki Y, Otsuka T, Losdat S, H\u00e4ner JD, Lonborg J, et al. Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial. JAMA. 2022;327:1771\u201381.","journal-title":"JAMA"},{"key":"8469_CR42","unstructured":"Zhang LJ. Role of screening with coronary computed tomography angiography in primary prevention of coronary heart disease (RESPECT). https:\/\/clinicaltrials.gov\/study\/NCT05431309."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08469-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08469-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08469-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T19:09:39Z","timestamp":1727723379000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08469-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8469"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08469-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol has been approved by the ethics committee of the Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University. We will obtain written informed consent from each patient before they are randomized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent will be obtained and the model consent form can be made available. No identifying images or other personal or clinical details of participants will be presented in reports of the trial results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"635"}}